| Customization: | Available |
|---|---|
| Application: | Surgery |
| Usage Mode: | Intravenous Administration |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Artesunate Injection is prescribed for the initial treatment of severe malaria in adults as well as pediatric patients.
In order to treat severe malaria, artesunate 60 mg should always be followed by a complete treatment course of an oral antimalarial regimen.
Dosage: The recommended artesunate dosage is 2.4 mg/kg, should be administered intravenously at 0 hours, 12 hours, and 24 hours, and thereafter, administered once in a day until the patient is able to tolerate oral antimalarial therapy. Administered constituted injections intravenously as a slow bolus over 1-2 minutes. Do not administer inj falcigo 60 mg via continuous intravenous infusion.
Treatment Reactions:
The most commonly observed artesunate side effects may include:
If you experience any of the adverse events listed above, report your healthcare provider right away.
Storage: Store vials of inj falcigo as well as sterile diluent at 20°C-25°C (68°F-77°F); excursions permitted to 15°C-30°C (59°F-86°F). Never freeze falcigo and exposure to heat should be avoided. Use beyond the expiration date is not recommended
){kind=link}